Essent Biologics™, a leading supplier of human-derived cell and scaffold materials, today announced availability for investigational researchers to obtain human pre-eclamptic cytotrophoblasts and Hofbauer cells through its distribution agreement with the Amnion Foundation. The Amnion Foundation successfully isolated cytotrophoblasts and Hofbauer cells from the post-partum placenta of a donor with confirmed pre-eclampsia, enabling researchers to further investigate disease mechanisms at the cellular level and identify key differences in health and disease.
